TAGAMET

This brand name is authorized in Brazil, Japan, Mexico, South Africa, UK.

Active ingredients

The drug TAGAMET contains one active pharmaceutical ingredient (API):

1	Cimetidine UNII 80061L1WGD - CIMETIDINE
	Cimetidine is a histamine H2-receptor antagonist which rapidly inhibits both basal and stimulated gastric secretion of acid and reduces pepsin output. It is a reversible, competitive antagonist, and is used as an anti-ulcer drug.
	Read more about Cimetidine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
Tagamet 200mg Tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BA01	Cimetidine	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BA H2-receptor antagonists
Discover more medicines within A02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510607601115412, 510607602111410, 510607604114417
GB	Medicines & Healthcare Products Regulatory Agency	24000
JP	医薬品医療機器総合機構	2325001C1053, 2325001F1211, 2325001F2048, 2325400A1077
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	89032
ZA	Health Products Regulatory Authority	J/11.4.3/307, J/11.4.3/308, J/11.4.3/309, P/11.4.3/173, S/11.4.3/328, T/11.4.3/22